Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights Abbott Laboratories, Koninklijke Philips and Smith & Nephew

Read MoreHide Full Article

For Immediate Release

Chicago, IL – October 3, 2023 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Abbott Laboratories (ABT - Free Report) , Koninklijke Philips (PHG - Free Report) and Smith & Nephew SNATS (SNN - Free Report) .

Here are highlights from Monday’s Analyst Blog:

3 Medical Product Stocks with Solid Dividend Yields

The Zacks Medical - Products industry is suffering from headwinds like raging inflation, higher interest rates, supply-chain disruptions and high operating costs. These factors are likely to hurt the margin for the industry players.

Amid these ongoing headwinds, the industry has declined 8.8% until Sep 28, underperforming the S&P 500 Index’s 12.5% gain and the broader Zacks Medical sector’s 7.6% decline.

Owing to the rising market volatility, it would be a wise decision to focus on some dividend-paying companies like Abbott Laboratories, Koninklijke Philips and Smith & Nephew SNATS from the Medical - Products industry to create a steady income source. These companies have consistently announced dividend hikes, thus highlighting their pro-shareholder stance.

Stocks that have a strong history of dividend growth belong to mature companies, which are less susceptible to large swings in the market, and act as a hedge against economic or political uncertainty as well as stock market volatility. At the same time, they offer downside protection with a consistent rise in payouts.

Additionally, these companies have superior fundamentals like a sustainable business model, a long track of profitability, good liquidity, a strong balance sheet and some value characteristics.

3 Medical Products Stocks to Embrace Now

In order to choose some of the best dividend stocks from the industry, we have run the Zacks Stock Screener to identify those with a dividend yield in excess of 2% and a sustainable dividend payout ratio of less than 60%.

Abbott Laboratories: Headquartered in Chicago, IL, Abbott Laboratories discovers, develops, manufactures and sells a diversified line of healthcare products. The company pays out a quarterly dividend of 51 cents ($2.04 annualized) per share, which gives it a 2.12% yield at the current stock price. This company’s payout ratio is 48%, with a five-year dividend growth rate of 14.01%. (Check Abbott’s dividend history here.)

We are impressed with Abbott’s consistent efforts to reward its shareholders through dividends and share repurchases. In February 2023, it announced an 8.5% hike in its quarterly dividend, taking the total to 51 cents per share (annualized $2.04). The company is also active on the buyback front. During the first half of 2023, ABT repurchased approximately 7 million shares for a total cost of $725 million. It currently has $1.71 billion available for repurchase under the share repurchase program, authorized by the board of directors in December 2021.

Koninklijke Philips: Headquartered in the Netherlands, Koninklijke Philips engages in diagnosis, treatment, monitoring & analytics, population health management, oral healthcare, mother & child care and personal care.

The company pays annualized dividends of 93 cents per share, giving it a 4.51% yield at the current stock price. Its payout ratio is 76%, with a five-year dividend growth rate of 0.39%. (Check Koninklijke Philips’ dividend history here.)

We are impressed with Koninklijke Philips’ efforts to reward its shareholders through dividends and buybacks. Its board of directors increased the annual cash dividend from 78 cents per share to 93 cents in 2023, indicating a dividend hike of 19.2%. The company is also active on the buyback front. During the fourth quarter of 2022, PHG repurchased 2.2 million shares under its share buyback program for an amount of up to 1.5 billion euros, announced in 2021. The company had contracts in place to buyback 17.4 million shares by 2022-end at a contracted value of 648 million euros.

Smith & Nephew: Headquartered in Engalnd, Smith & Nephew is a global medical device company that markets clinically superior products, principally in orthopaedics, endoscopy and wound management. SNN pays out a quarterly dividend of 28 cents ($0.90 annualized) per share, which gives it a 3.61% yield at the current stock price. This company’s five-year dividend growth rate is 3.5%. (Check Smith & Nephew’s dividend history here.)

Why Haven’t You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

See More Zacks Research for These Tickers

Normally $25 each - click below to receive one report FREE:

Abbott Laboratories (ABT) - free report >>

Koninklijke Philips N.V. (PHG) - free report >>

Smith & Nephew SNATS, Inc. (SNN) - free report >>

Published in